Nanolipogels delivering cancer drugs, illustration. At centre right is a cutaway depiction of a nanolipogel (NLG, spherical), carrying drugs in the bloodstream (blood vessel in background) to target cancer cells (purple, bottom). The NLGs break down to release IL-2 (interleukin-2, green) to stimulate the body's immune system, along with a TGF-beta (transforming growth factor) inhibitor drug (blue) to block the growth of the cancer. NLGs consist of lipid layers surrounding a hydrogel core. This drug delivery technique was developed at Yale University, with support from the National Science Foundation (NSF). Image published in 2012. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Nicolle Rager Fuller, National Science Foundation |
Bildgröße: | 2846 px × 3694 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: | - |